GoodRx Holdings (GDRX) Non Operating Income (2019 - 2026)

GoodRx Holdings has disclosed Non Operating Income across 8 years of filings, most recently posting -$8.4 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at -$8.4 million, down 24.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.7 million (up 66.05% YoY), and the FY2025 annual result was $718000.0, up 102.09% from the prior year.
• Non Operating Income came in at -$8.4 million for Q1 2026 at GoodRx Holdings, down from $24000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $18.5 million in Q4 2022 to a low of -$12.3 million in Q3 2024.
• The 5-year median for Non Operating Income is -$6.7 million (2025), against an average of -$3.6 million.
• Across the five-year window, Non Operating Income surged 414.08% in 2022 and plunged 99.49% in 2025, its largest moves.
• GoodRx Holdings' Non Operating Income stood at $18.5 million in 2022, then plunged by 144.74% to -$8.3 million in 2023, then surged by 156.83% to $4.7 million in 2024, then slumped by 99.49% to $24000.0 in 2025, then plunged by 34975.0% to -$8.4 million in 2026.
• The last three Non Operating Income figures came in at -$8.4 million (Q1 2026), $24000.0 (Q4 2025), and $694000.0 (Q2 2025), per Business Quant data.